Optimising urinary catecholamine metabolite diagnostics for neuroblastoma

Yvette A H Matser, Iedan R N Verly, Maria van der Ham, Monique G M de Sain-van der Velden, Nanda M Verhoeven-Duif, Shifra Ash, Giuliana Cangemi, Sebastiano Barco, Maja Beck Popovic, André B P van Kuilenburg, Godelieve A M Tytgat ; SIOPEN Catecholamine Working Group

Pediatr Blood Cancer. 2023 Jun;70(6):e30289. doi: 10.1002/pbc.30289. Epub 2023 Apr 3

Previous
Previous

Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma

Next
Next

Radiotherapy quality assurance in paediatric clinical trials: first report from six QUARTET-affiliated trials